☰

Kimberly E. Foreman - Publications

Affiliations: 
Molecular and Cellular Biochemistry Program Loyola University Chicago, Chicago, IL, United States 
Area:
Cell Biology
Tree Info Similar researchers PubMed Report error

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Blackwell RH, Foreman KE, Gupta GN. The Role of Cancer-Derived Exosomes in Tumorigenicity & Epithelial-to-Mesenchymal Transition. Cancers. 9. PMID 28796150 DOI: 10.3390/Cancers9080105  0.437
2016 Greco KA, Franzen CA, Foreman KE, Flanigan RC, Kuo PC, Gupta GN. PLK-1 Silencing in Bladder Cancer by siRNA Delivered with Exosomes. Urology. PMID 26876462 DOI: 10.1016/J.Urology.2016.01.028  0.379
2016 Foreman K, Mitchell A, White S, Bielecki E, Picken M, Gupta G. MP83-16 EMETINE DIHYDROCHLORIDE ENHANCES CISPLATIN/GEMCITABINE-MEDIATED GROWTH INHIBITION OF BLADDER TUMOR CELLS IN VIVO Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2198  0.428
2016 Davidson VJ, Blackwell RH, Foreman KE, Kuo PC, Flanigan RC, Gupta GN. MP83-02 ADDITION OF EMETINE DIHYDROCHLORIDE TO PLATINUM BASED CHEMOTHERAPY INHIBITS BLADDER CANCER CELL PROLIFERATION AND REDUCES THE EFFECTIVE DOSE OF PLATINUM CHEMOTHERAPY Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2184  0.428
2016 Blackwell RH, Franzen C, Zilliox M, Foreman KE, Kuo PC, Flanigan RC, Gupta GN. MP83-01 URINARY SHED BLADDER CANCER EXOSOMES HAVE DISTINCT MRNA PROFILES AND HAVE POTENTIAL AS URINARY BIOMARKERS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2183  0.303
2015 Franzen CA, Blackwell RH, Foreman KE, Kuo PC, Gupta GN. Urinary Exosomes: The Potential for Biomarker Utility, Intercellular Signaling and Therapeutics in Urological Malignancy. The Journal of Urology. PMID 26714199 DOI: 10.1016/J.Juro.2015.08.115  0.352
2015 Franzen C, Greco K, Blackwell R, Foreman K, Gupta G. Mp49-08 Urothelial Cells Undergo Epithelial To Mesenchymal Transition After Exposure To Muscle Invasive Bladder Cancer Exosomes The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.512  0.355
2015 Foreman KE, Patel D, Davidson V, Kuo P, Flanigan R, Gupta GN. MP45-09 EMETINE DIHYDROCHLORIDE PREFERENTIALLY INHIBITS HIF1α AND HIF2α EXPRESSION IN BLADDER CANCER CELLS Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1507  0.446
2014 Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. Biomed Research International. 2014: 619829. PMID 24575409 DOI: 10.1155/2014/619829  0.43
2014 Foreman KE, Jesse JN, Kuo PC, Gupta GN. Emetine dihydrochloride: a novel therapy for bladder cancer. The Journal of Urology. 191: 502-9. PMID 24045224 DOI: 10.1016/J.Juro.2013.09.014  0.387
2014 Van Huis A, Franzen C, Foreman K, Gupta G. MP39-10 EXOSOME-MEDIATED REGULATION OF PTEN EXPRESSION IN BLADDER CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1325  0.374
2014 Greco KA, Franzen CA, Kuo PC, Foreman KE, Flanigan RC, Gupta GN. MP34-16 PLK1 SILENCING IN BLADDER CANCER BY SIRNA DELIVERED WITH EXOSOMES Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1029  0.36
2012 Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, ErÅŸahin Ç, Rajan P. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. International Journal of Surgical Pathology. 20: 139-45. PMID 22084425 DOI: 10.1177/1066896911427035  0.461
2011 Speiser JJ, Foreman K, Drinka EK, Godellas C, Perez C, Ersahin C, Salhadar A, Rajan P. Abstract 3135: Notch 1 and notch 4 biomarker expression in triple-negative invasive breast cancer Cancer Research. 71: 3135-3135. DOI: 10.1158/1538-7445.Am2011-3135  0.431
2010 Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, Strack PR, Golde TE, Miele L, Foreman KE. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Research. 30: 3853-67. PMID 21036696  0.595
2010 Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L. Targeting Notch to target cancer stem cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3141-52. PMID 20530696 DOI: 10.1158/1078-0432.Ccr-09-2823  0.501
2009 Grudzien P, Strack P, Golde T, Miele L, Foreman K. Inhibition of Notch signaling reduces the stem-like cell population in T47D breast cancer cells and prevents mammosphere formation. Cancer Research. 69: 106. DOI: 10.1158/0008-5472.Sabcs-106  0.519
2009 Foreman K, Grudzien P, Lo S, Robinson P, Albain K, Strack P, Miele L. Blockade of Notch Signaling with Gamma-Secretase Inhibitors Induces Apoptosis in the Stem-Like Population of Breast Cancer Cells. Cancer Research. 69: 1154-1154. DOI: 10.1158/0008-5472.Sabcs-09-1154  0.534
2008 Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 27: 5124-31. PMID 18758481 DOI: 10.1038/Onc.2008.226  0.485
2007 Curry CL, Reed LL, Broude E, Golde TE, Miele L, Foreman KE. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Molecular Cancer Therapeutics. 6: 1983-92. PMID 17604336 DOI: 10.1158/1535-7163.Mct-07-0093  0.612
2006 Curry CL, Reed LL, Nickoloff BJ, Miele L, Foreman KE. Notch-independent regulation of Hes-1 expression by c-Jun N-terminal kinase signaling in human endothelial cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 86: 842-52. PMID 16732296 DOI: 10.1038/Labinvest.3700442  0.616
2005 Curry CL, Reed LL, Golde TE, Miele L, Nickoloff BJ, Foreman KE. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene. 24: 6333-44. PMID 15940249 DOI: 10.1038/Sj.Onc.1208783  0.633
2004 Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, Detmar M. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nature Genetics. 36: 683-5. PMID 15220917 DOI: 10.1038/Ng1383  0.556
2003 Foreman KE, Tang J. Molecular mechanisms of replicative senescence in endothelial cells. Experimental Gerontology. 38: 1251-7. PMID 14698804 DOI: 10.1016/J.Exger.2003.09.005  0.406
2003 Paner GP, Jensen J, Foreman KE, Reyes CV. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leukemia & Lymphoma. 44: 1811-4. PMID 14692539 DOI: 10.1080/1042819031000104015  0.303
2003 Chaturvedi V, Bonish B, Bacon P, Qin JZ, Denning MF, Foreman K, Diaz MO, Robinson J, Nickoloff BJ. Role for Id-1 in immunobiology of normal keratinocytes and in basal cell carcinoma. Experimental Dermatology. 12: 255-60. PMID 12823438 DOI: 10.1034/J.1600-0625.2003.00066.X  0.356
2003 Tang J, Gordon GM, Müller MG, Dahiya M, Foreman KE. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. Journal of Virology. 77: 5975-84. PMID 12719589 DOI: 10.1128/Jvi.77.10.5975-5984.2003  0.439
2002 Tang J, Gordon GM, Nickoloff BJ, Foreman KE. The helix-loop-helix protein id-1 delays onset of replicative senescence in human endothelial cells. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 1073-9. PMID 12177246 DOI: 10.1097/01.Lab.0000022223.65962.3A  0.402
2002 Lu C, Gordon GM, Chandran B, Nickoloff BJ, Foreman KE. Human herpesvirus 8 reactivation and human immunodeficiency virus type 1 gp120. Archives of Pathology & Laboratory Medicine. 126: 941-6. PMID 12171492 DOI: 10.1043/0003-9985(2002)126<0941:Hhrahi>2.0.Co;2  0.323
2001 Foreman KE, Friborg J, Chandran B, Katano H, Sata T, Mercader M, Nabel GJ, Nickoloff BJ. Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions. Journal of Dermatological Science. 26: 182-93. PMID 11390203 DOI: 10.1016/S0923-1811(01)00087-1  0.332
2000 Mercader M, Taddeo B, Panella JR, Chandran B, Nickoloff BJ, Foreman KE. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. The American Journal of Pathology. 156: 1961-71. PMID 10854219 DOI: 10.1016/S0002-9440(10)65069-9  0.335
1999 Foreman KE, Wrone-Smith T, Krueger AE, Nickoloff BJ. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation. Clinical Immunology (Orlando, Fla.). 91: 345-53. PMID 10370381 DOI: 10.1006/Clim.1999.4712  0.375
1998 Friborg J, Kong WP, Flowers CC, Flowers SL, Sun Y, Foreman KE, Nickoloff BJ, Nabel GJ. Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas. Journal of Virology. 72: 10073-82. PMID 9811747 DOI: 10.1128/Jvi.72.12.10073-10082.1998  0.375
1997 Bonish BK, Foreman KE, Gutierrez-Steil C, Nickoloff BJ. Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis. Journal of Dermatological Science. 16: 52-8. PMID 9438908 DOI: 10.1016/S0923-1811(97)00621-X  0.417
1997 Foreman KE, Bacon PE, Hsi ED, Nickoloff BJ. In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. The Journal of Clinical Investigation. 99: 2971-8. PMID 9185521 DOI: 10.1172/Jci119492  0.386
Show low-probability matches.